LAVYX
Price
$15.19
Change
+$0.19 (+1.27%)
Updated
Dec 20 closing price
VIVAX
Price
$66.44
Change
+$0.77 (+1.17%)
Updated
Dec 20 closing price
Ad is loading...

LAVYX vs VIVAX

Header iconLAVYX vs VIVAX Comparison
Open Charts LAVYX vs VIVAXBanner chart's image
Lord Abbett Fundamental Equity I
Price$15.19
Change+$0.19 (+1.27%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$66.44
Change+$0.77 (+1.17%)
VolumeN/A
CapitalizationN/A
LAVYX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVYX vs. VIVAX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVYX is a Buy and VIVAX is a Hold.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. LAVYX (1.89B). VIVAX pays higher dividends than LAVYX: VIVAX (2.25) vs LAVYX (0.94). LAVYX was incepted earlier than VIVAX: LAVYX (22 years) vs VIVAX (32 years). LAVYX is a more actively managed with annual turnover of: 26.00 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than LAVYX: VIVAX (3000) vs LAVYX (1000000). VIVAX (15.15) and LAVYX (15.03) have marching annual gain over last year. VIVAX return over 5 years is better than : 41.35 vs. LAVYX (30.72).
LAVYXVIVAXLAVYX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years32 years-
Gain YTD14.25514.000102%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.89B195B1%
Annual Yield % from dividends0.942.2542%
Returns for 1 year15.0315.1599%
Returns for 3 years14.7718.2581%
Returns for 5 years30.7241.3574%
Returns for 10 years20.8599.5321%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.560.12
+4.92%
CytoMed Therapeutics Limited
AQN4.390.08
+1.86%
Algonquin Power & Utilities Corp
BIIB146.47-0.92
-0.62%
Biogen
DOLE13.70-0.11
-0.80%
Dole plc
BNTC11.52-0.64
-5.30%
Benitec Biopharma